Research Perspective
What is the link between lymphedema and obesity? The bidirectional interaction between obesity and lymphatic injury By Babak Mehrara and George Kokosis
L
ymphedema is a major worldwide problem afflicting over 200 million patients1. A common cause of lymphedema in the United States—and most developed countries—is cancer treatment. In these procedures, lymph nodes or lymphatic channels are injured during the course of cancer staging or treatment; in approximately 20-50% of patients, this injury leads to the development of lymphedema. While breast cancer treatment is the most common cause of cancer-related lymphedema in developed countries, this disease also occurs commonly in patients treated for gynecological or urologic cancers, melanoma, head and neck cancer and sarcoma. It is estimated that at least six million patients in the United States have lymphedema, and many are related to obesity itself. To put the scale of this problem in perspective, this number of patients is roughly equivalent to the number of Americans who suffer from Alzheimer’s disease and nearly six times the number of patients with Parkinson’s disease.
Obesity is a major risk factor for development of lymphedema Researchers have identified a number of risk factors for lymphedema development. This research is useful for patient education and early intervention approaches; in some cases, risk factors are modifiable and can be changed to decrease the risk of disease development. Although there is debate about the degree of risk for some putative risk factors for cancer-related lymphedema—increasing age,
Dr. Babak Mehrara, MD, is the chief of the Division of Plastic and Reconstructive Surgery at Memorial Sloan Kettering Cancer Center in New York. His clinical interests include microsurgical oncologic reconstruction. He is also the principal investigator in his NIH funded laboratory studying pathophysiology and treatment of lymphedema. Dr. George Kokosis, MD, is currently a microsurgical reconstructive fellow in the Plastic and Reconstructive Surgery program at Memorial Sloan Kettering Cancer Center. He has completed his surgical training at Johns Hopkins hospital. His clinical and research interests include surgical treatment of lymphedema and associated clinical and patient reported outcomes.
Summer 2020
the use of adjuvant radiation therapy, the type of chemotherapy used for cancer treatment, among others—a large body of evidence supports the idea that obesity is a major risk factor for disease development2. In breast cancer survivors, studies have shown that obesity—usually defined as patients with a body mass index (BMI)>30— increases the risk of lymphedema by 3-400%3,4,5. Even gaining weight after surgery in otherwise thin patients increases the risk of lymphedema5,6. Along the same vein, a randomized-controlled-trial comparing patients with arm lymphedema who received nutritional consultation and support for 12 weeks versus patients who were simply given a pamphlet on weight loss measures, showed that active intervention resulted in weight loss and also significantly improved arm swelling7. These studies are important because they show that obesity and lymphedema are related and that dietary modifications or behavioral changes are an important adjunct to the treatment of the disease. Ly m p h e d e m a p a t h w a y s . c a 5